Fundamental Expertise

Biologics are the fastest growing segment of the pharmaceutical market displaying fierce competition among its players. The coming rise of biosimilars and the development of immunotherapies, new antibody variants as well as cell & gene therapies are constantly adding to the treatment landscape.

Project examples:

• Carve-out strategy for European biotech company
  During the externalization of a portfolio of therapeutic antibodies Biovisory supported the set-up of a NewCo structure, R&D strategy and clinical development planning and guided the fundraising support for a ~40 Mio€ financing round. 
  

• Executive management for European biotech company
  Chief operating officer, responsible for all operations (including inhouse GMP manufacturing), Project management and Business development, with a portfolio of immuno-onco biologicals from preclinical stage to market approval.